|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ПсковГУ |
||
Improvement of conventional perception in stable patients with schizophrenia by add-on treatment with ipidacrineстатья Электронная публикация Исследовательская статья Краткое сообщение Тезисы
Статья опубликована в высокорейтинговом журнале
Статья опубликована в журнале из списка Web of Science и/или ScopusДата последнего поиска статьи во внешних источниках: 6 октября 2021 г.
- Авторы: Morozova M., Beniashvili A., Potanin S., Rupchev G., Burminskiy D., Lepilkina T.
- Журнал: European Psychiatry
- Том: 64
- Номер: 1
- Год издания: 2021
- Издательство: Cambridge University Press
- Местоположение издательства: United Kingdom
- Первая страница: 656
- Последняя страница: 656
- DOI: 10.1192/j.eurpsy.2021.1408
- Аннотация: Impairment of conventional perception is one of the key dysfunction in patients with schizophrenia even absence of psychotic symptoms. Objective. Possibility of improvement of conventional perception by add-on treatment with ipidacrine in patients with schizophrenia in long-term remission.Material and methods. 26 (13 females) patients, mean age 40.4 (SD 11.7) with episodic schizophrenia in remission, receiving stable antipsychotic therapy were included into the open label study. As add-on treatment ipidacrine was administered once per day in dosage 20 mg for two months. Positive and Negative Symptoms Scale (PANSS) was used to assess clinical symptoms and projective psychological method (Rorschach Test) was used to assess conventional perception.ResultsThe study showed that ipidacrine in a low dosage, added to standard antipsychotic treatment, was effective in relation to negative symptoms (PANSS negative subscale score before 22,4 (SD4,7) and after beginning of the study 19,7 (4,5), p=0, 001). Of all the indicators of the Rorschach test, there was significant improvement in the index X+%, which is responsible for the degree of conventionality in reality recognition. The decrease in conventionality was associated with both high individualism and perceptual disorders. The value of of X+ % did not reach the standard one (70%) to the end of the study, but the improvement showed the switching from severe (52,4 (SD 12,2) to moderate (60,6 (SD10,4) impairment level (p=0,039).ConclusionIpidacrine in a low dosage as add-on treatment has positive impact on conventional perception of stable patients with schizophrenia even in short-term trial.
- Добавил в систему: Рупчев Георгий Евгеньевич
Прикрепленные файлы
| № | Имя | Описание | Имя файла | Размер | Добавлен |
|---|